Iris Grossman, PhD
Evaluator · DISC type DCSIris Grossman is the Chief Therapeutics Officer at Eleven Therapeutics, bringing over 20 years of experience from both Big Pharma and biotech startups. A graduate of Technion, she is a leader in personalized medicine, RNA therapeutics, and AI in drug discovery, with a focus on neurological and metabolic diseases.
Iris is passionate about mentorship and is actively involved with Executive Women In Bio (eWIB), where she chairs several initiatives. Her focus is on empowering other professionals and paying forward her knowledge within the life sciences community.
Interesting fact: Iris was named one of the "Top 40 under 40" by Globes, a prominent Israeli business publication, for her significant contributions to the industry.
Read the full overview →How Iris shows up
They focus on the results, but can still be quite procedural and analytical about how to get there They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical They are not very likely to become strong advocates of your product or service
Topics Iris cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.